Immune Therapeutics Inc (IMUN)

OTC Markets
5.75
-0.04(-0.69%)
  • Volume:
    605
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    5.50 - 5.815

IMUN Overview

Prev. Close
5.79
Day's Range
5.5-5.815
Revenue
-
Open
5.5
52 wk Range
2.5-49.9
EPS
5.53
Volume
605
Market Cap
2.77M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,289
P/E Ratio
1.04
Beta
0.98
1-Year Change
-59.65%
Shares Outstanding
481,906
Next Earnings Date
31 Aug 2021
What is your sentiment on Immune Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellStrong Sell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryNeutralNeutralNeutralStrong SellStrong Sell

Immune Therapeutics Inc Company Profile

Immune Therapeutics Inc Company Profile

Employees
0

Immune Therapeutics, Inc. is a biotechnology company. The Company is involved in the manufacturing, distribution and marketing of therapies to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using its patented immunotherapy. The Company’s products and immunotherapy technologies are designed to improve the treatment of cancer, infections, such as human immunodeficiency virus (HIV)/acquired immuno deficiency syndrome (AIDS), chronic inflammatory diseases and autoimmune diseases. Its technology platform is built on various immunotherapies, such as Low Dose Naltrexone (LDN) and Methionine-Enkephalin (MENK). Its technology offers treatment for a range of cancers. The Company’s clinical programs involve immunotherapy with Methionine-Enkephalin (MENK) (sometimes referred to as opioid growth factor) and its Low Dose Naltrexone (LDN) product or LodonalTM, which stimulates the immune system even in patients with advanced cancer.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.